Glycobiology vol 4 no 4 pp. 451-458, 1994
© 1994
research-article |
Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor
Glycomed Inc. 860 Atlantic Avenue, Alameda, CA 94501, USA
1To whom correspondence should be addressed
Received on January 13, 1994; revised on March 18, 1994; accepted on March 21, 1994
The biological activity of basic fibroblast growth factor (bFGF) is influenced greatly by direct binding to heparin and heparan sulphate (HS). Heparin-derived oligosaccharides have been utilized to determine the structural requirements present in the polymer that account for bind ing to bFGF. We had previously demonstrated that fragments >6 mer can inhibit the interaction between cell surface heparan sulphate proteoglycan (HSPG) and bFGF, and bFGF-induced proliferation of adrenocortical endothelial (ACE) cells. In contrast, oligosaccharides > 10 mer can enhance the binding of bFGF to its high-affinity receptor or support bFGF-induced mitogenesis in ACE cells (Ishihara et al., J. Biol. Chem., 268, 4675–4683, 1993). We have extended these studies to size- and structure-defined oligosaccharides from heparin, 2-O-desulphated (2-O-DS-) heparin, 6-O-desulphated (6-O-DS-) heparin, carboxyreduced (CR-) heparin and carboxy-amidomethylsulphonated (AMS-) heparin. Oligosaccharides from these polymers were fractionated on a bFGF-affinity column and were assessed as inhibitors or enhancers of specific bFGF-derived biological activities. The results of these studies indicate that both 2-O-sulphate and the negative charge of the carboxy group [L-iduronic acid (IdoA) residues] are required for specific interactions of heparin-derived oligosaccharides with bFGF and for modulation of bFGF mitogenic activity. In addition, the charge of the carboxy groups in uronic acids can be replaced by other functional groups with a negative charge, such as the amidomethyl sulphonate moiety described here.
basic fibroblast growth factor heparan sulphate heparin oligosaccharides
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Ashikari-Hada, H. Habuchi, N. Sugaya, T. Kobayashi, and K. Kimata Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate Glycobiology, June 1, 2009; 19(6): 644 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Baumann Biological Effects of Heparan Sulfates and Regioselectively Modified Heparin-Heparan Mimetics Journal of Bioactive and Compatible Polymers, January 1, 2003; 18(1): 59 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Jemth, J. Kreuger, M. Kusche-Gullberg, L. Sturiale, G. Gimenez-Gallego, and U. Lindahl Biosynthetic Oligosaccharide Libraries for Identification of Protein-binding Heparan Sulfate Motifs. EXPLORING THE STRUCTURAL DIVERSITY BY SCREENING FOR FIBROBLAST GROWTH FACTOR (FGF) 1 AND FGF2 BINDING J. Biol. Chem., August 16, 2002; 277(34): 30567 - 30573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lyon, G. Rushton, J. A. Askari, M. J. Humphries, and J. T. Gallagher Elucidation of the Structural Features of Heparan Sulfate Important for Interaction with the Hep-2 Domain of Fibronectin J. Biol. Chem., February 18, 2000; 275(7): 4599 - 4606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Pye and J. T. Gallagher Monomer Complexes of Basic Fibroblast Growth Factor and Heparan Sulfate Oligosaccharides Are the Minimal Functional Unit for Cell Activation J. Biol. Chem., May 7, 1999; 274(19): 13456 - 13461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wei and S. J. Swiedler Functional Analysis of Conserved Cysteines in Heparan Sulfate N-Deacetylase-N-sulfotransferases J. Biol. Chem., January 22, 1999; 274(4): 1966 - 1970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Pye, R. R. Vives, J. E. Turnbull, P. Hyde, and J. T. Gallagher Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity J. Biol. Chem., September 4, 1998; 273(36): 22936 - 22942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. van Kuppevelt, M. A. B. A. Dennissen, W. J. van Venrooij, R. M. A. Hoet, and J. H. Veerkamp Generation and Application of Type-specific Anti-Heparan Sulfate Antibodies Using Phage Display Technology. FURTHER EVIDENCE FOR HEPARAN SULFATE HETEROGENEITY IN THE KIDNEY J. Biol. Chem., May 22, 1998; 273(21): 12960 - 12966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Satoh, M. Susaki, C. Shukunami, K.-i. Iyama, T. Negoro, and Y. Hiraki Functional Analysis of Diastrophic Dysplasia Sulfate Transporter. ITS INVOLVEMENT IN GROWTH REGULATION OF CHONDROCYTES MEDIATED BY SULFATED PROTEOGLYCANS J. Biol. Chem., May 15, 1998; 273(20): 12307 - 12315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamane, R. Tohno-oka, S. Yamada, S. Furuya, K. Shiokawa, Y. Hirabayashi, H. Sugino, and K. Sugahara Molecular Characterization of Xenopus Embryo Heparan Sulfate. DIFFERENTIAL STRUCTURAL REQUIREMENTS FOR THE SPECIFIC BINDING TO BASIC FIBROBLAST GROWTH FACTOR AND FOLLISTATIN J. Biol. Chem., March 27, 1998; 273(13): 7375 - 7381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. G. Brickman, M. D. Ford, J. T. Gallagher, V. Nurcombe, P. F. Bartlett, and J. E. Turnbull Structural Modification of Fibroblast Growth Factor-binding Heparan Sulfate at a Determinative Stage of Neural Development J. Biol. Chem., February 20, 1998; 273(8): 4350 - 4359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Dvorak, A Hampl, L Jirmanova, J Pacholikova, and M Kusakabe Embryoglycan ectodomains regulate biological activity of FGF-2 to embryonic stem cells J. Cell Sci., January 10, 1998; 111(19): 2945 - 2952. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Skaletz-Rorowski, A. Schmidt, G. Breithardt, and E. Buddecke Heparin-Induced Overexpression of Basic Fibroblast Growth Factor, Basic Fibroblast Growth Factor Receptor, and Cell-Associated Proteoheparan Sulfate in Cultured Coronary Smooth Muscle Cells Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 1063 - 1069. [Abstract] [Full Text]
|
|
|
|
|
|
X. Bai and J. D. Esko An Animal Cell Mutant Defective in Heparan Sulfate Hexuronic Acid 2-O-Sulfation J. Biol. Chem., July 26, 1996; 271(30): 17711 - 17717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Hoffman, D. Paper, J Donaldson, S Alban, and G Franz Characterisation of a laminarin sulphate which inhibits basic fibroblast growth factor binding and endothelial cell proliferation J. Cell Sci., January 11, 1995; 108(11): 3591 - 3598. [Abstract] [PDF]
|
|
|
|
|
|
Y. Kariya, M. Kyogashima, K. Suzuki, T. Isomura, T. Sakamoto, K. Horie, M. Ishihara, R. Takano, K. Kamei, and S. Hara Preparation of Completely 6-O-Desulfated Heparin and Its Ability to Enhance Activity of Basic Fibroblast Growth Factor J. Biol. Chem., August 18, 2000; 275(34): 25949 - 25958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kreuger, M. Salmivirta, L. Sturiale, G. Gimenez-Gallego, and U. Lindahl Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2 J. Biol. Chem., August 10, 2001; 276(33): 30744 - 30752. [Abstract] [Full Text] [PDF]
|
|